Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Tara Budinetz"'
Autor:
Daniel Griffin, Claudio Benadiva, Tara Budinetz, Carolina Sueldo, Andrea DiLuigi, John Nulsen, Lawrence Engmann
Publikováno v:
Contemporary Clinical Trials Communications, Vol 8, Iss C, Pp 18-24 (2017)
Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of controlled ovarian stimulation. The use of gonadotropin releasing hormone (GnRH) agonist for the trigger of oocyte maturation is effective in the prevention of OHSS although it
Externí odkaz:
https://doaj.org/article/29af380e9f8f4b3ab7dbee357a7fcb83
Autor:
Randy Morris, Maria Doukakis, Annette Lee, Steven Hirshberg, Mark Leondires, Eric K. Seaman, John Nichols, Michael J. Butcher, Joshua Hurwitz, Gianpiero D. Palermo, Fady I. Sharara, James A. Kashanian, Joshua A Bodie, Jennifer Nichols, Matthew Wosnitzer, Gail Whitman-Elia, Spencer Richlin, Zev Rosenwaks, M. Sobel, Peter Ahlering, Natan Bar-Chama, Shaun Williams, Cynthia Murdock, G. Charles Ostermeier, Tara Budinetz, Jay S. Schinfeld, Larry I. Barmat, Mira Aubuchon, John Payne, Travis W. McCoy, Edward Tarnawa, Alexander J. Travis, S.G. Somkuti, Ilana Ressler, Lauren Weissmann
Publikováno v:
Reproductive BioMedicine Online. 41:69-79
Can a previously defined relationship between sperm capacitation and the probability of a man generating pregnancy within three cycles, prospectively predict male fertility in diverse clinical settings? A second study asked, what is the prevalence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3f85e96b276ffb965acdc87d865c919
https://doi.org/10.1016/j.rbmo.2020.03.011
https://doi.org/10.1016/j.rbmo.2020.03.011
Autor:
A. Diluigi, Lawrence Engmann, C.M. Sueldo, Daniel Griffin, John Nulsen, Tara Budinetz, Claudio Benadiva
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 8, Iss C, Pp 18-24 (2017)
Contemporary Clinical Trials Communications, Vol 8, Iss C, Pp 18-24 (2017)
Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of controlled ovarian stimulation. The use of gonadotropin releasing hormone (GnRH) agonist for the trigger of oocyte maturation is effective in the prevention of OHSS although it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ffca9cc8e4dd98323c0e6b2083b1833
https://doi.org/10.1016/j.conctc.2017.08.008
https://doi.org/10.1016/j.conctc.2017.08.008
Autor:
Claudio Benadiva, Bat-Sheva L. Maslow, John Nulsen, Lawrence Engmann, Tara Budinetz, Carolina Sueldo
Publikováno v:
Journal of Assisted Reproduction and Genetics. 31:1643-1646
Ectopic pregnancies are one of the few conditions which constitute a gynecologic emergency, as it may result in a life threatening complication. The incidence in the general population is approximately 2 % [1]; however a significant increase has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01d3b0ba9862fa44fa56176716c4cdd3
https://doi.org/10.1007/s10815-014-0338-5
https://doi.org/10.1007/s10815-014-0338-5
Publikováno v:
Fertility and Sterility. 102:753-758
Objective To compare the rate of congenital anomalies, obstetrical complications, and neonatal complications in antagonist cycles where either GnRH agonist (GnRHa) or hCG was used for final oocyte maturation. Design Retrospective cohort study. Settin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f72564f8b41bb0b7f5f00bf29e56ef3
https://doi.org/10.1016/j.fertnstert.2014.05.030
https://doi.org/10.1016/j.fertnstert.2014.05.030
Publikováno v:
Fertility and Sterility. 97:1316-1320
To compare live birth rates after dual trigger of oocyte maturation with GnRH agonist (GnRHa) and low-dose hCG versus GnRHa alone in high responders with peak E(2)4,000 pg/mL at risk of ovarian hyperstimulation syndrome (OHSS).Retrospective cohort st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61ff2df5460dcad1d0c422804840c9cd
https://doi.org/10.1016/j.fertnstert.2012.03.015
https://doi.org/10.1016/j.fertnstert.2012.03.015
Autor:
Bat-Sheva L. Maslow, Lawrence Engmann, Tara Budinetz, Carolina Sueldo, Claudio Benadiva, John Nulsen, Erica Anspach
Publikováno v:
Obstetrics and gynecology. 126(1)
OBJECTIVE: To compare the analysis of chromosome number from paraffin-embedded products of conception using single-nucleotide polymorphism (SNP) microarray with the recommended screening for the evaluation of couples presenting with recurrent pregnan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc6635801fde7d112d5d4608b4bcea84
https://pubmed.ncbi.nlm.nih.gov/26241271
https://pubmed.ncbi.nlm.nih.gov/26241271
Publikováno v:
Fertility and sterility. 103(3)
To determine the ovulation rate after ovulation induction with clomiphene citrate (CC) in women who had previously been ovulatory after a stair-step (CC-SS) ovulation induction.Retrospective cohort.University-based tertiary fertility center.61 anovul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8181c3588ecb928ce636230ec9c4abc0
https://pubmed.ncbi.nlm.nih.gov/25577463
https://pubmed.ncbi.nlm.nih.gov/25577463
Autor:
Marc Lalande, Noelle D. Germain, Stormy J. Chamberlain, Kristen Martins-Taylor, Estela Cruvinel, Tara Budinetz
Publikováno v:
Human molecular genetics. 23(17)
Prader-Willi syndrome (PWS), a disorder of genomic imprinting, is characterized by neonatal hypotonia, hypogonadism, small hands and feet, hyperphagia and obesity in adulthood. PWS results from the loss of paternal copies of the cluster of SNORD116 C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::863b129076bc972b4d8c942265c21832
https://pubmed.ncbi.nlm.nih.gov/24760766
https://pubmed.ncbi.nlm.nih.gov/24760766
Autor:
Daniel Griffin, Richard Feinn, Claudio Benadiva, Tara Budinetz, Lawrence Engmann, John Nulsen
Publikováno v:
Fertility and sterility. 102(2)
Objective To evaluate the percentage (%) of mature oocytes retrieved in patients with a previous history of >25% immature oocytes retrieved who were triggered with gonadotropin-releasing hormone agonist (GnRH-a) and human chorionic gonadotropin (hCG)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75869fd92b8c2c497ee8fa386a37027f
https://pubmed.ncbi.nlm.nih.gov/24842671
https://pubmed.ncbi.nlm.nih.gov/24842671